DexCom Case Study: Launching a continuous glucose monitor

Published Date: 31/12/2011
Category: Diagnostics & Imaging

Research Report Decription

Continuous glucose monitors promise better management of diabetes. This report examines the CGM market, and the competitive pressures that DexCom and Medtronic face.Continuous glucose monitors (CGMs) promise certain diabetics more effective self-management of their condition. Medtronic is a leading US supplier of CGMs, but since 2006 it has faced competition from a small start-up, DexCom. This case study examines the market for CGMs, and the competitive pressures that DexCom and Medtronic face. 

Key Questions Answered:

• Why is glucose monitoring important for diabetes management?
• Why are continuous glucose monitors challenging periodic test monitors?
• Who are the leading players in the US continuous glucose monitor market?

Companies Mentioned:

DexCom, Medtronics

Paper Highlights:

Management of diabetes often requires electronic blood glucose testing. Continuous monitors came on to the US market in 2001 and offer some diabetics better management of their condition than periodic test devices. Medtronic is the market leader, but its position is being challenged by DexCom. Substitutes, new entrants, and buyer power are significant pressures in the US CGM market.